WebNews
Please enter a web search for web results.
NewsWeb
CNPV: A gamechanger for the pharma industry or simply more chaos?
1+ hour, 57+ min ago (1192+ words) As the pharma and biotech editor at WTWH Media, Brian has almost two decades of experience in B2 B media, with a focus on healthcare and technology. While he has long maintained a keen interest in AI, more recently Brian has…...
J&J poster puts Spravato remission data at center of treatment-resistant-depression growth push
1+ week, 2+ hour ago (228+ words) Drug Discovery and Development By Brian Buntz | June 12, 2026 Rakesh Jain, MD, MPH Of the trials included is J&J's ESCAPE-TRD record, which describes a Phase 3 interventional trial comparing flexible-dose esketamine nasal spray with quetiapine XR, both with SSRI/SNRI background…...
ADA conference: GLP-1 results, police remove researchers
1+ week, 10+ hour ago (840+ words) Drug Discovery and Development By Julia Rock-Torcivia | June 12, 2026 Eli Lilly, Novo Nordisk, Astra Zeneca and more announced recent GLP-1 clinical and preclinical data at the American Diabetes Association's (ADA's) national conference this week. Security staff asked the researchers to step…...
Boehringer Ingelheim eyes MASH as the next front for survodutide
1+ week, 1+ day ago (226+ words) Drug Discovery and Development By Brian Buntz | June 11, 2026 "We have a program in MASH, in the liver, the LIVERAGE program, plus a robust data-generation program to come over the next couple of years, because we want to bring a comprehensive…...
Blazing new paths for biotech
1+ week, 2+ day ago (154+ words) Drug Discovery and Development By Brian Finrow & Kevin Klowden | June 10, 2026 But the investing weather has changed: there is now greater caution both from U. S. regulators and investors, which has dovetailed with both a surplus of capital and increased regulatory streamlining in…...
Ginkgo, Tangible and Inductive Bio aim to move ADME decisions from lead optimization to hit ID
1+ week, 3+ day ago (570+ words) Drug Discovery and Development By Brian Buntz | June 10, 2026 The new ADME-One platform packages Ginkgo's automated Tier 1 assays, Tangible's compound-management workflow and Inductive Bio's human pharmacokinetic projection into a single service aimed at hit identification. The aim is to give medicinal…...
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson's
1+ week, 4+ day ago (207+ words) Drug Discovery and Development By Brian Buntz | June 8, 2026 "There's an app for that." The app side of Remepy's hybrid drug tracks daily movement against a goal and prompts patients to log symptoms like pain and stiffness. (Image: Remepy) A trends…...
CEPI fast-tracks three ebola vaccine candidates
2+ week, 1+ day ago (427+ words) Drug Discovery and Development By Julia Rock-Torcivia | June 4, 2026 There are currently no licensed vaccines for BDBV, and none are in clinical development. There have only been two previous outbreaks caused by this virus." "With Bundibugyo virus spreading rapidly and no…...
Rubedo turns a senescence-targeting drug on precancerous skin, and sees an efficacy signal without the intense redness
2+ week, 3+ day ago (343+ words) Drug Discovery and Development By Brian Buntz | June 2, 2026 "What we tell patients, and I've written hundreds of these prescriptions, is that if you don't get irritation you won't get improvement. The same is true for imiquimod," said Beddingfield, referring to…...
Salesforce lands 140 life sciences clients, pitches 'headless' AI to pharma
2+ week, 4+ day ago (482+ words) Drug Discovery and Development By Brian Buntz | June 1, 2026 A patient support program overview over dedicated to improving treatment adherence. (Image: Salesforce) "The 140 represents customers across our entire portfolio," said Joe Ferraro, SVP and GM of life sciences at Salesforce, "regardless…...